Mechanisms of evasion of neutrophil killing by Anaplasma phagocytophilum

被引:50
作者
Carlyon, JA
Fikrig, E
机构
[1] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Chandler Med Ctr, Lexington, KY 40536 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA
关键词
apoptosis; human granulocytic anaplasmosis; human granulocytic ehrlichiosis; intracellular pathogen; oxidative killing;
D O I
10.1097/01.moh.0000190109.00532.56
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review. This review summarizes recent knowledge regarding the strategies employed by Anaplasma phagocytophilum to evade or subvert neutrophil killing mechanisms and modify other neutrophil pathways to promote its survival. Recent findings. A. phagocytophilum evades neutrophil oxidative killing by preventing fusion of cytochrome b(558)-carrying specific granules and secretory vesicles with the membrane of its cytoplasmic compartment. It also directly detoxifies superoxide anion. Additionally, the bacterium alters the interaction of transcription factors with the CYYB promoter, which results in greatly reduced gp91(phox) levels and a consequent decline in respiratory burst capability. A. phagocytophilum not only fails to activate the normal neutrophil apoptosis differentiation program stimulated by bacterial uptake, but also delays spontaneous apoptosis by manipulating the expression of pro and antiapoptotic genes. Maintenance of the proapoptotic factor Bfl-1 contributes, at least in part, to the preservation of mitochondrial membrane integrity and inhibition of caspase 3 activation. Summary. A. phagocytophilum combats neutrophil oxidative killing by scavenging O-2(-), inhibiting NADPH oxidase assembly on its vacuolar membrane, and modifying promoter activity for a key NADPH oxidase component, gp91(phox). Uptake of this unique pathogen fails to induce neutrophil apoptosis. Furthermore, A. phagocytophilum extends the life of its otherwise short-lived host cell by dysregulating neutrophil gene expression and molecular machinery to potentially maximize its survival and dissemination within its mammalian host.
引用
收藏
页码:28 / 33
页数:6
相关论文
共 36 条
[1]   Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase [J].
Banerjee, R ;
Anguita, J ;
Fikrig, E .
INFECTION AND IMMUNITY, 2000, 68 (07) :4361-4362
[2]   Cutting edge:: Infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox1 [J].
Banerjee, R ;
Anguita, J ;
Roos, D ;
Fikrig, E .
JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :3946-3949
[3]   Insights into pathogen immune evasion mechanisms:: Anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils [J].
Borjesson, DL ;
Kobayashi, SD ;
Whitney, AR ;
Voyich, JM ;
Argue, CM ;
DeLeo, FR .
JOURNAL OF IMMUNOLOGY, 2005, 174 (10) :6364-6372
[4]   Chlamydia and apoptosis:: Life and death decisions of an intracellular pathogen [J].
Byrne, GI ;
Ojcius, DM .
NATURE REVIEWS MICROBIOLOGY, 2004, 2 (10) :802-808
[5]   Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection [J].
Carlyon, JA ;
Latif, DA ;
Pypaert, M ;
Lacy, P ;
Fikrig, E .
INFECTION AND IMMUNITY, 2004, 72 (08) :4772-4783
[6]  
Carlyon JA, 2002, J IMMUNOL, V169, P7009, DOI 10.4049/jimmunol.169.12.7009
[7]  
CARLYON JA, 2004, 63 S SOC GEN MICR BI, P301
[8]   Anaplasma phagocytophilum infection induces protracted neutrophil degranulation [J].
Choi, KS ;
Grab, DJ ;
Dumler, JS .
INFECTION AND IMMUNITY, 2004, 72 (06) :3680-3683
[9]   Early induction and late abrogation of respiratory burst in A-phagocytophilum -: Infected neutrophils [J].
Choi, KS ;
Dumler, JS .
RICKETTSIOLOGY: PRESENT AND FUTURE DIRECTIONS, 2003, 990 :488-493
[10]   Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin [J].
Choi, KS ;
Garyu, J ;
Park, J ;
Dumler, JS .
INFECTION AND IMMUNITY, 2003, 71 (08) :4586-4594